Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
This announcement reaffirms the Scottish Medicines Consortium’s decision of 10 February 2025, meaning that no disease-modifying therapies for Alzheimer’s disease are currently approved for use in Scotland.
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
ADI calls for lived experience to be central to innovation in the field of dementia diagnostics, treatment and care. In her short interview with Novartis, Paola Barbarino highlights key areas which innovators must consider when developing their products and service, from inception, to testing and ultimately bringing them to market; and reminds us not to forget that simple innovative changes can lead to great impact.
Diego Aguilar, Regional Director for the Americas gives his insights on the recent ADI members meeting for Latin America and the Caribbean, held in San Juan, Puerto Rico in early December 2023.
Centre for Applied Dementia Studies at the University of Bradford becomes the first institution in Europe to receive the ADI Accreditation, marking a historic milestone for University of Bradford and ADI
This November, African regional members from across the continent including Botswana, Burundi, Cameroon, Ethiopia, France, Ghana, Kenya, Madagascar, Mauritius, Nigeria, Sénégal, South Africa, Uganda and Zimbabwe, convened in…
DY Suharya, Director of ADI Asia Pacific, and Shyh Poh Teo, Director of Demensia Brunei, reflect on the 2023 Asia Pacific Regional Conference as co-organisers of the event.
The resulting declaration includes an essential call for Member States of the WHO to extend the Global Action Plan on dementia to 2035
Each year, ADI hosts its Alzheimer University for emerging associations, aiming to equip new associations with the skills and knowledge needed to run a successful Alzheimer or dementia association.
The annual event brings together basic scientists, clinical researchers, early career investigators, clinicians and the care research community to discuss the latest developments and innovation in Alzheimer’s and dementia research.